These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 25964245)

  • 1. Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison.
    Gonzalez BD; Jim HS; Booth-Jones M; Small BJ; Sutton SK; Lin HY; Park JY; Spiess PE; Fishman MN; Jacobsen PB
    J Clin Oncol; 2015 Jun; 33(18):2021-7. PubMed ID: 25964245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic inflammation and symptomatology in patients with prostate cancer treated with androgen deprivation therapy: Preliminary findings.
    Hoogland AI; Jim HSL; Gonzalez BD; Small BJ; Gilvary D; Breen EC; Bower JE; Fishman M; Zachariah B; Jacobsen PB
    Cancer; 2021 May; 127(9):1476-1482. PubMed ID: 33378113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in physical functioning and muscle strength in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison.
    Gonzalez BD; Jim HSL; Small BJ; Sutton SK; Fishman MN; Zachariah B; Heysek RV; Jacobsen PB
    Support Care Cancer; 2016 May; 24(5):2201-2207. PubMed ID: 26563183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison.
    Lee M; Jim HS; Fishman M; Zachariah B; Heysek R; Biagioli M; Jacobsen PB
    Psychooncology; 2015 Apr; 24(4):472-7. PubMed ID: 24924331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Course and Moderators of Hot Flash Interference during Androgen Deprivation Therapy for Prostate Cancer: A Matched Comparison.
    Gonzalez BD; Jim HS; Donovan KA; Small BJ; Sutton SK; Park J; Lin HY; Spiess PE; Fishman MN; Jacobsen PB
    J Urol; 2015 Sep; 194(3):690-5. PubMed ID: 25791402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and predictors of fatigue among men receiving androgen deprivation therapy for prostate cancer: a controlled comparison.
    Nelson AM; Gonzalez BD; Jim HS; Cessna JM; Sutton SK; Small BJ; Fishman MN; Zachariah B; Jacobsen PB
    Support Care Cancer; 2016 Oct; 24(10):4159-66. PubMed ID: 27142516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term androgen deprivation therapy on cognitive function over 36 months in men with prostate cancer.
    Alibhai SM; Timilshina N; Duff-Canning S; Breunis H; Tannock IF; Naglie G; Fleshner NE; Krahn MD; Warde P; Marzouk S; Tomlinson GA
    Cancer; 2017 Jan; 123(2):237-244. PubMed ID: 27583806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: preliminary findings.
    Jim HS; Park JY; Permuth-Wey J; Rincon MA; Phillips KM; Small BJ; Jacobsen PB
    Brain Behav Immun; 2012 Oct; 26(7):1030-6. PubMed ID: 22475653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep disturbance in men receiving androgen deprivation therapy for prostate cancer: The role of hot flashes and nocturia.
    Gonzalez BD; Small BJ; Cases MG; Williams NL; Fishman MN; Jacobsen PB; Jim HSL
    Cancer; 2018 Feb; 124(3):499-506. PubMed ID: 29072790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.
    Keto CJ; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
    BJU Int; 2012 Aug; 110(4):492-8. PubMed ID: 22094083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: A controlled comparison.
    Donovan KA; Gonzalez BD; Nelson AM; Fishman MN; Zachariah B; Jacobsen PB
    Psychooncology; 2018 Jan; 27(1):316-324. PubMed ID: 28557112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric Impact of Androgen Deprivation Therapy in Patients with Prostate Cancer: Current Evidence and Recommendations for the Clinician.
    Siebert AL; Lapping-Carr L; Morgans AK
    Eur Urol Focus; 2020 Nov; 6(6):1170-1179. PubMed ID: 32690473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer.
    Cherrier MM; Aubin S; Higano CS
    Psychooncology; 2009 Mar; 18(3):237-47. PubMed ID: 18636420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Beck Depression Inventory scores in prostate cancer patients undergoing androgen deprivation therapy or prostatectomy.
    Shin D; Shim SR; Kim CH
    PLoS One; 2020; 15(6):e0234264. PubMed ID: 32542009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 2-year prospective analysis of insomnia as a mediator of the relationship between androgen deprivation therapy and perceived cognitive function in men with prostate cancer.
    Garland SN; Savard J; Eisel SL; Wassersug RJ; Rockwood NJ; Thoms J; Jim HSL; Gonzalez BD
    Cancer; 2021 Dec; 127(24):4656-4664. PubMed ID: 34411294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Bill-Axelson A;
    Eur Urol Oncol; 2018 Jun; 1(2):134-142. PubMed ID: 31100237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis.
    McGinty HL; Phillips KM; Jim HS; Cessna JM; Asvat Y; Cases MG; Small BJ; Jacobsen PB
    Support Care Cancer; 2014 Aug; 22(8):2271-80. PubMed ID: 24859915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressive symptoms are found to be potential adverse effects of androgen deprivation therapy in older prostate cancer patients: A 15-month prospective, observational study.
    Zhang Z; Yang L; Xie D; Shi H; Li G; Yu D
    Psychooncology; 2017 Dec; 26(12):2238-2244. PubMed ID: 28474429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of walking exercise in promoting cognitive-psychosocial functions in men with prostate cancer receiving androgen deprivation therapy.
    Lee CE; Kilgour A; Lau YK
    BMC Cancer; 2012 Jul; 12():324. PubMed ID: 22846379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: A mixed methods study.
    Wu LM; Tanenbaum ML; Dijkers MP; Amidi A; Hall SJ; Penedo FJ; Diefenbach MA
    Soc Sci Med; 2016 May; 156():80-9. PubMed ID: 27019142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.